Silk Road Medical, Inc
SILK · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $51 | $48 | $47 | $44 |
| % Growth | 5.7% | 2.6% | 6.4% | – |
| Cost of Goods Sold | $13 | $12 | $12 | $12 |
| Gross Profit | $39 | $37 | $35 | $32 |
| % Margin | 75.1% | 75.3% | 73.6% | 72.9% |
| R&D Expenses | $12 | $11 | $10 | $10 |
| G&A Expenses | $0 | $0 | $39 | $0 |
| SG&A Expenses | $44 | $41 | $39 | $36 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | -$0 |
| Operating Expenses | $56 | $51 | $49 | $46 |
| Operating Income | -$17 | -$15 | -$14 | -$14 |
| % Margin | -33.6% | -30.8% | -30.4% | -30.8% |
| Other Income/Exp. Net | $1 | $1 | $1 | $1 |
| Pre-Tax Income | -$17 | -$14 | -$13 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$17 | -$14 | -$13 | -$13 |
| % Margin | -32.4% | -29.2% | -27.5% | -28.8% |
| EPS | -0.42 | -0.36 | -0.33 | -0.33 |
| % Growth | -16.7% | -9.1% | 0% | – |
| EPS Diluted | -0.42 | -0.36 | -0.33 | -0.33 |
| Weighted Avg Shares Out | 40 | 39 | 39 | 39 |
| Weighted Avg Shares Out Dil | 40 | 39 | 39 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $3 | $3 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$14 | -$11 | -$10 | -$10 |
| % Margin | -27.2% | -23.7% | -21.9% | -22.8% |